- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
-
Endocrine Care
Mohammadkhani G, Jalilzadeh Afshari P., Jalaei S., Nasli Esfahani E. , Majidi H
Auditory Event Related Potentials in Type 1 Diabetes MellitusActa Endo (Buc) 2013 9(2): 263-272 doi: 10.4183/aeb.2013.263
AbstractBackground. Type 1 diabetes mellitus is a common disorder which causes a variety of complications such as cognitive deficits in central nervous system. Auditory P300 event related potential is a wellestablished neurophysiologic approach in the assessment of cognitive performance. In this study, we aimed to evaluate the cognitive performance in insulin dependent diabetic patients by auditory event related potentials. Methods. In this descriptive analytical and non-interventional study, auditory P300 event related potential was measured in oddball paradigm by using two tone burst stimuli (1000 & 2000 Hz) on 25 diabetic patients and 25 age, education and sex matched healthy controls, with mean age 28.76±4.1 in patients and 29.68±3.6 in controls. Results. The mean P300 latency of the diabetic patients was significantly prolonged and the mean P300 amplitude of the diabetic patients was significantly lower when compared with that of controls at all electrode sites (p<0.01). Also there was a strong correlation between P300 latency and glucose level, HbA1c and diabetes duration (p<0.01). Conclusion. Auditory information processing is slower and the speed of information categorizing is lower in diabetic patients than in controls. -
Images in Endocrinology
Niculescu DA, Dumitrascu A, Lica I
Neck tumoral swelling in an endemic iodine deficiency areaActa Endo (Buc) 2010 6(2): 263-263 doi: 10.4183/aeb.2010.263
-
General Endocrinology
Mihaescu G, Olinescu R, Oancea F
Metabolic syndrome may be improved following a long-time administration of a nutritive supplement containing embryonary peptidesActa Endo (Buc) 2005 1(3): 263-270 doi: 10.4183/aeb.2005.263
Abstract ReferencesMetabolic Syndrome (MS) is a polymorph disease with a high frequency especially in older age. Any randomized study with nonhospitalized subjects might include those bearing MS, that greatly influenced the final results. Eighty subjects aged 50-75 years (38 men and 42 women) had consumed daily 4 caps of purified Embryonary Peptides (EP) for 60 days. The samples of blood from each subject were obtained before and after administration. Therefore, each subject was his own control. In all subjects, after administration, regardless of the MS presence, total cholesterol and LDL-cholesterol had decreased approximately 30 % as compared with the initial values. Significant decreases of insulin and cortisol were also observed, but associated with modifications of PSA, CEA and IGF-l. The magnitude of these changes was lower in subjects with MS. The long-lasting modifications induced by EP seem to have an adaptive-regulatory character, affecting the lipid metabolism (already modified in MS), as well as some pathways from steroid biosynthesis. Thus, EP might act similarly to some stimulatory factors, such as IGF-1, in a reversible stage of MS.1. Reaven GM. Role of insulin resistance in human diseases. Diabetes 1988; 37: 1595-1599. [CrossRef]2. Despres JP. Potential contribution of metformin to the management of cardio-vascular risk in patients with abdominal obesity and type 2 diabetes. Diab. Metab. 2003; 29: 6S53-6S59.3. Hancu N., Roman G., Nita C. et al. Metabolic Syndrome - Practical Approach. Roman. J. Inter, Med. 2004; 42(2): 237-246.4. Mota M., Panus C., Mota E. et al. Metabolic Syndrome - a multifaced disease. Roman. J. Intern. Med. 2004; 42(2): 247-256.5. Gruia IM. Olinescu R., Mihaescu G. The modification of oxidative stress in elderly after Orgasel and Humanofort treatment. Infomedica 1997; 11: 40-44.6. Mihaescu G., Olinescu R., Oancea F., Significant modifications of lipid metabolism in aged persons following the administration of a nutritive supplement. Rom. J. Intern. Med. 2006 - in press.7. Jaffiel C. Le Syndrome Polymetabolique ou Obesite Maligne. Roum. J. Endocrinol. Metabolism, 2005; 4(3): 14-20.8. Vaughan CJ., Murphy MB., Buckley BM., Statins do more than lower cholesterol. Lancet l996; 348-352.9. Serpoi G., Cucu C., Transaminases are significantly increased in patients with metabolic syndrome when compared with obese controls. Acta Endocrinologica 2005; 1(1): 19-30. [CrossRef]10. Olinescu R., Smith TL., Physiologic Effects of Oxidative Stress: Aging, in: Olinescu R. and Smith TL, Free Radicals in Medicine, Nova Science Publ.Inc. New York, 2002; 120-126.11. Kummerow FA, Olinescu R., Fleischer L. et al. The relationship of oxidized lipids to coronary artery stenosis. Atherosclerosis, 2000; 149: 181-190.12. Marcus MA., White GC., Insulin sensitivity and serum triglyceride level in obese white and black women. Metabolism, 1999; 48: 143-149.13. Czeh MP. New perspectives on the mechanism of insulin action. Recent Progress Hormone Res. 1984; 40: 347-360.14. Landin WS., Lappas G., Serum IGF-1 in random population sample of men and women. Clin. Endocrinol. Oxford, 1994; 41: 351-357. -
Case Report
Sethi SM, Vohra M, Ali SA
Euglycemic Diabetic Ketoacidosis (EDKA) in a Patient Receiving DapagliflozinActa Endo (Buc) 2021 17(2): 266-269 doi: 10.4183/aeb.2021.266
Abstractyears because of their cardio-protective and renoprotective properties in diabetes. SGLT-2 inhibitors, when introduced in diabetic patients, may cause euglycemic diabetic ketoacidosis. A 55-year-old woman presented with low-grade fever, vomiting, and lethargy. She was started on dapagliflozin two years back. On workup, she was diagnosed with euglycemic diabetic ketoacidosis (EDKA) and was managed accordingly. She improved clinically while her dapagliflozin was stopped. With a literature search, we have identified 15 case reports of EDKA with dapagliflozin since 2015. There are no standard guidelines regarding the monitoring of patients for this rare but potentially morbid complication. Moreover, the exact mechanism for this is unknown. Various precipitating factors are linked with SGLT-2 inhibitors in promoting EDKA. We recommend that customary plans should comprise educating the patient about this rare complication before commencing medication, close follow-up with serial electrolyte monitoring, and discontinuing medications in the state of infection, dehydration and recent surgery and serious illness requiring hospitalization. -
Case Report
Iliescu L, Toma L, Minzala G, Orban C
Acute Hepatitis after Methimazole. Case ReportActa Endo (Buc) 2014 10(2): 267-272 doi: 10.4183/aeb.2014.267
AbstractBackground. There are few cases of methimazole induced hepatitis. The mechanism is probably related to the fact that it is a hepatic- metabolised drug. Objective. To demonstrate the fact that an acute cholestatic hepatitis can be triggered by methimazole. Design. While dealing with a major cholestatic syndrome with cytolysis, we performed the following steps: correct and complete history, serum detection of acute viral hepatitis, an autoimmune cause and finally liver biopsy. Subjects and Methods. We present the case of an 80 year old woman, with a history of hyperthyroidism, in treatment with Methimazole. After a month, the patient developed jaundice, for which she was admitted to our clinic. On admission she presented an important cholestatic syndrome, with elevated transaminases (5 times normal). Results. None of the laboratory tests indicated a possible viral infection or autoimmune disease. Abdominal ultrasound revealed no possible obstruction of the biliary system. Ultimately we performed a liver biopsy, which revealed inflammatory infiltration and cholestasis. Conclusion. We conclude that the hepatitis was induced by methimazole. Corticotherapy was initiated, with a relatively slow but favourable evolution. I131- Radiation therapy was elected for the treatment of hyperthyroidism. -
General Endocrinology
Badescu SV, Tataru CP, Kobylinska L, Zahiu CD, Georgescu EL,Zagrean L, Zagrean AM
Chronic Caffeine’s Effects on Behavioural Changes in Streptozotocininduced Diabetic RatsActa Endo (Buc) 2016 12(3): 268-274 doi: 10.4183/aeb.2016.268
AbstractContext. Memory deficits, anxiety and depression are often associated with diabetes, worsening diabetic patients’ prognosis. Caffeine, a worldwide used psychoactive substance, is a candidate for improving these conditions. Objective. The aim of this study was to assess the behaviour in streptozotocin-induced diabetic Wistar rats and to evaluate the behavioural effects of caffeine administration. Materials and methods. Diabetes was induced by a single intraperitoneal injection of 50 mg/kg BW streptozotocin (n=10), while control rats received the vehicle (n=9). After six weeks, behavioural tests for anxiety, memory and depression were performed: elevated plus maze (EPM) test, novel object recognition (NOR) test and forced swimming test (FST), respectively. The tests were repeated after further 2 weeks of continuous caffeine administration (20 mg/kg BW/day in drinking water). Results. Diabetic rats manifested a high anxiety level, showed by a reduced exploratory activity compared to control rats (p<0.05) and long-term memory impairment, spending more time near the old object in NOR test. Caffeine administered for 2 weeks did not modify glycemic values in either group, and attenuated the behavioural changes observed in the EPM test. Also, in NOR test for long-term memory, caffeine administration induced an increased time spent with the novel object than with the old one in both groups. Conclusions. Our data suggest that chronic caffeine administration has an anxiolytic effect in diabetic rats and improves long-term memory in both diabetic and control rats. -
Letter to the Editor
Shao J, Wu X, Liu X, Qi J, Qi Z
The Correlation between Neck Circumference and Umbilical Artery Blood Flow in Physiologic PregnanciesActa Endo (Buc) 2018 14(2): 268-271 doi: 10.4183/aeb.2018.268
AbstractObjective. To study the correlation between neck circumference(NC) and umbilical artery blood flow in physiologic pregnancies. Methods. One hundred and one healthy pregnant woman in the third trimester were enrolled. Anthropometric measurements and ultrasonic testing were done. Results. The women with NC ≥34.7cm had a more elevated umbilical artery pulsatility index(PI) and systolic/diastolic ratio (S/D) than the women with NC <34.7cm (P<0.01). NC were positively correlated with PI(r=0.224,P=0.024) and S/D ratio(r=0.415,P=0.0001). In multivariate analysis, NC was independently associated with PI (β=0.026, P=0.016) and S/D ratio (β=0.132, P=0.0001). Conclusions. Obesity has an adverse impact on feto-placetal vessels, and NC was superior to body mass index. -
General Endocrinology
Liu F, Duan JT, Teng X, Peng DQ
The Increased Plasma Levels of Intermedin in Patients with Type 2 Diabetes MellitusActa Endo (Buc) 2022 18(3): 271-277 doi: 10.4183/aeb.2022.271
AbstractContext. Intermedin (IMD) is the member of calcitonin gene-related peptide family, and tightly associated with type 2 diabetes mellitus (T2DM). The change of plasma IMD levels in T2DM is still unknown. Objective. We aimed to investigate the plasma levels of IMD in patients with T2DM. Design. Fortyone patients with T2DM who were hospitalized in the endocrinology department of Civil Aviation General Hospital from January 2012 to June 2015 were enrolled, and 44 volunteers were selected as the control group. Subjects and Methods. Plasma level of IMD was detected by ELISA. Diagnostic value of IMD was analyzed by area under the receiver operating characteristic (ROC) curve (AUC). Results. The plasma level of IMD in T2DM group was higher than that in the healthy control group, whereas smoking or cardiovascular complications did no influence the IMD levels. IMD levels were correlated with BMI, DBP, triglyceride, uric acid, urea nitrogen, fasting and 2 hours postprandial blood glucose, and HbA1C. The greatest value of AUC for IMD was only 58.73%. Conclusions. Although plasma levels of IMD were increased in patients with T2DM, the very low diagnostic value of IMD for T2DM might not be used for the disease diagnosis. -
Case Report
Chentli F, Belahcene S, Rezzoug M, Fedala NS, Belhimer F
McCune Albright Syndrome with a Somatolactotroph Pituitary Adenoma Causing Gigantism: Econography and Literature ReviewActa Endo (Buc) 2011 7(2): 273-282 doi: 10.4183/aeb.2011.273
AbstractMcCune Albright syndrome (MAS) is a rare disease due to a sporadic mutation in Gs protein inducing polyostotic fibrous\r\ndysplasia, pigmented skin patches and hyper functioning endocrinopathies. We aimed to report its association with a hot thyroid nodule and gigantism.\r\nCase report. A man aged 37, with a history of pigmented skin lesions and lameness was referred for acromegaly. He was giant (height = 1.94 m/ target stature = 1.68 m), and had ?caf? au lait? spots. Biological analyses argued for pituitary mixed secretion (random growth hormone = 22 ng/ mL, N<5; prolactin = 27 ng/mL, N<10). Brain CT scan showed a pituitary process of 11x10 mm. Thyroid radioiodine scan revealed a hot nodule. Bone x-ray demonstrated large osteolytic lesions in the right femur and pelvis. He was operated on for endocrine tumours. The thyroid nodule\r\nwas benign and immunohistochemistry pituitary was positive for GH, prolactin and α subunit.\r\nConclusion. Somatolactotrop adenoma causing gigantism associated with MAS is exceptional. It should be known, diagnosed, and treated early to avoid bone deformations\r\nand malignant transformation of osseous lesions under GH and/or IGF1 excess. One should also know that radiotherapy for the pituitary process is contraindicated, because of higher risk of sarcomatous transformation. -
General Endocrinology
Giurgiuca A, Schipor S, Caragheorgheopol A, Crasan A, Postolache E, Tudose C, Prelipceanu D , Cozman D
Platelet Serotonin as Biomarker for Assessing Suicidal Behaviour in Patients with Bipolar I DisorderActa Endo (Buc) 2016 12(3): 275-281 doi: 10.4183/aeb.2016.275
AbstractContext. Suicide is a global public health issue. Bipolar disorder (BPD) has the highest suicide risk among individuals suffering from mental disorders. Serotoninergic dysfunctions have been linked to suicidal behaviour and platelet serotonin is recognised as a reliable index for the presynaptic serotonin activity. Objective. Our aim was to assess whether alterations occur in platelet serotonin concentrations in BPD type I in respect to suicide attempters compared with nonattempters. Design. This was a cross-sectional, observational study. Subjects and Methods. Plasma platelet serotonin concentrations were measured using ELISA technique in 71 BPD I patients. The participants were assigned into 3 groups (non-attempters, low lethality and high lethality suicide attempters), according to the Columbia-Suicide Severity Rating Scale. Socio-demographical and clinical data was obtained by using MINI 6.0 and a semi-structured questionnaire designed specifically for this research. Results. Our study showed significant lower levels of platelet serotonin in suicide attempters compared with non-attempters (p = 0.030) and in high-lethality attempters compared with low-lethality attempters (p = 0.015). The study recorded a higher number of total lifetime and lifetime depressive episodes for suicide attempters with BPD I. Conclusions. Our results subscribe to the importance of platelet serotonin as a reliable biomarker in suicide risk assessment.